Predictive Biochemical Model of Frailty and Mortality After Acute Myocardial Infarction

Area of Science:

• Gerontology
• Cardiology
• Biochemistry

Background:

• Frailty, a state of reduced resilience, predicts poor outcomes in myocardial infarction patients.
• The Fried score is a common frailty assessment tool but has limitations.
• Biomarkers may offer a more objective measure of frailty and prognosis.

Purpose of the Study:

• To investigate the relationship between frailty and blood biomarkers in elderly acute coronary syndrome patients.
• To assess the predictive value of these biomarkers for long-term mortality.
• To compare a biochemical frailty model with the Fried score.

Main Methods:

• Two cohorts of elderly patients (>65) hospitalized for acute coronary syndrome were analyzed.
• Geriatric assessments and blood biomarkers were measured.
• Logistic and Cox regression models were used to develop predictive and survival models.

Main Results:

• Nine biomarkers were significantly associated with frailty in 466 patients.
• White blood cells count, hemoglobin, and fibrinogen demonstrated the highest predictive power.
• A model without GDF-15 predicted mortality better than the Fried score; GDF-15 improved frailty correlation but not survival prediction.

Conclusions:

• Frailty in acute coronary syndrome is associated with physiological dysregulation reflected in blood biomarkers.
• Biomarker-based frailty assessment provides valuable prognostic information in this patient group.
• The inclusion of GDF-15 did not enhance the predictive accuracy for mortality.